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Purpose: To study acquired color vision and visual ﬁ  eld defects in patients with ocular 
hypertension (OH) and early glaucoma.
Methods: In a prospective study we evaluated 99 eyes of 56 patients with OH without visual ﬁ  eld 
defects and no hereditary color deﬁ  ciencies, followed up for 4 to 6 years (mean = 4.7 ± 0.6 years). 
Color vision defects were studied using a special computer program for Farnsworth–Munsell 
100 hue test and visual ﬁ  eld tests were performed with Humphrey analyzer using program 30–2. 
Both tests were repeated every six months.
Results: In ﬁ  fty-six eyes, glaucomatous defects were observed during the follow-up period. 
There was a statistically signiﬁ  cant difference in total error score (TES) between eyes that 
eventually developed glaucoma (157.89 ± 31.79) and OH eyes (75.51 ± 31.57) at the ﬁ  rst 
examination (t value 12.816, p  0.001). At the same time visual ﬁ  eld indices were within normal 
limits in both groups. In the glaucomatous eyes the earliest statistical signiﬁ  cant change in TES 
was identiﬁ  ed at the ﬁ  rst year of follow-up and was –20.62 ± 2.75 (t value 9.08, p  0.001) 
while in OH eyes was −2.11 ± 4.36 (t value 1.1, p = 0.276). Pearson’s coefﬁ  cient was high in all 
examinations and showed a direct correlation between TES and mean deviation and corrected 
pattern standard deviation in both groups.
Conclusion: Quantitative analysis of color vision defects provides the possibility of follow-up 
and can prove a useful means for detecting early glaucomatous changes in patients with normal 
visual ﬁ  elds.
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Introduction
Color vision is the ability to discriminate a light stimulus as a function of its wavelength. 
The sense of color is the end result of the absorption of several light stimuli from the 
three different types of cones and the following process and transmission of the sensory 
signal to the occipital cortex via the optic tract.1–3
Defects in the photoreceptors and the optic nerve ﬁ  bres will obviously cause 
a distortion of the color perception leading to an acquired color vision deﬁ  ciency 
(dyschromatopsia).4–8 Color vision defects in glaucoma have been described since 
1883.9 There are many forms of color vision deﬁ  ciencies, mainly affecting the 
red–green stimuli, blue–yellow stimuli, or randomly distributed in the chromatic cycle. 
The vast majority of the scientists suggest that the biggest defects in patients suffering 
from primary open-angle glaucoma (POAG) or ocular hypertension (OH) occur in the 
blue–yellow spectrum rather than the red–green spectrum.10–16
Patients and methods
This prospective study involves glaucoma suspects that were examined in the 
glaucoma department of the University Ophthalmology Hospital in Athens, Greece. Clinical Ophthalmology 2009:3 252
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Patients that were classiﬁ  ed as glaucoma suspects fulﬁ  lled 
one of the following criteria:
1.  OH was unilateral or bilateral with an intraocular pressure 
(IOP)  21 mmHg, without optic nerve head abnormalities 
or visual ﬁ  eld defects.
2.  POAG ‘in the contra-lateral eye’. In this occasion the 
eye to be examined did not have glaucomatous defects 
in fundoscopy or Humphrey visual ﬁ  eld (HVF) testing.
All eyes involved in the study had never received antiglau-
coma medication. The exclusion criteria were the following:
•  Congenital color vision defects
•  Presence of ophthalmic disease of any kind
•  Abnormality of the refraction media (cataract)
•  Best corrected visual acuity (VA) less than 16/20
•  Lack of ability for scheduled follow up
The aim of the study was to determine whether there is a 
correlation between the manifestation of color vision defects 
and glaucomatous visual ﬁ  eld defects.
All patients were examined and followed up according 
to a protocol that involved:
1.  Taking medical history
2.  Measurement of VA
3. Slit-lamp  examination
4. Gonioscopy
5. Fundoscopy
6. Phasing  of  IOP
7. HVF  testing
8.  Assessment of visual perception
9. Follow-up
Medical history
A thorough past medical and ophthalmological history 
including hereditary diseases of other family members was 
recorded for all patients. The excluding criteria involved 
patients with any disease that could affect visual function 
(diabetes mellitus, anemia, blood disorders, collagen 
disorders, administration of medicines, etc). Patients with 
congenital color vision defects or previous ophthalmic surgery 
or any eye disorder were also excluded from the study.
Visual acuity
Visual acuity was tested by one physician on the same 
optotype. Patients eligible for the study had VA equal to or 
more than 16/20 with maximum best corrected refraction 
less than six dioptres.
Slit-lamp examination
Slit-lamp examination was performed with a Haag–Streit 
900 slit-lamp.
The cornea was examined for topographic anomalies 
(pterygium, corneal scarring, etc) that could obstruct the 
accurate evaluation of IOP with a Goldmann applanation 
tonometer (GAT) and also for possible hazing that could 
inﬂ  uence VA.
The anterior chamber (AC) depth was evaluated, iris was 
examined for local atrophies, colobomas, neovascularization, 
presence of pseudo-exfoliation material, irregularities in the 
pupil, and the transparency of the crystalline lens. In case that an 
irregularity or an ophthalmic disease was observed the patient 
was considered no longer eligible to participate in the survey.
Gonioscopy
Gonioscopy was performed on the slit-lamp using the 
indirect Goldmann gonioscope. Patients with narrow angle, 
congenital dysgenesias of the anterior chamber’s angle and/or 
secondary glaucoma were excluded from the survey.
Fundoscopy
Slit-lamp ophthalmoscopy was done with a Goldmann 
three-mirror lens. An absolute prerequisite for a patient to 
take part in the study was the absence of any vitreoretinal 
disease. The cup/disc (c/d) ratio of the optic nerve head was 
studied thoroughly and all patients included in the study had 
horizontal and vertical c/d ratio less than 0.5.
IOP phasing
Intraocular pressure was measured at least three times a day 
(morning, afternoon, evening) for four consecutive days. 
All patients eventually involved had minimum two IOP 
measurements higher than 21 mmHg. The IOP was measured 
by a single doctor with the same Goldmann applanation 
tonometer following the HVF test and the assessment of 
visual perception.
Method of visual ﬁ  eld testing
We used automated perimetry with a 30-2 program of the 
Humphrey perimeter.
If the patient was examined for the ﬁ  rst time, the test had 
to be repeated within a short period of time and the second test 
was regarded as the baseline test in order to avoid misinter-
pretations due to the necessary learning curve for this testing 
method. It was necessary there was good patient reliability 
in order to evaluate the HVF test and in case of low patient 
reliability, the test had to be repeated within a week.
The inclusion criteria for characterizing glaucomatous 
lesions in a HVF test involve the presence of no less than 
one of the following:Clinical Ophthalmology 2009:3 253
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1. Glaucoma  hemiﬁ  eld test (GHT) outside normal limits.
2.  Three or more adjacent points with p  5% (nonedge 
30°) and one of them with p  1%.
3.  Corrected pattern standard deviation (CPSD)  5% (in a 
normal visual ﬁ  eld test regarding the rest of the parameters).
Method of examining the visual 
perception
The initial basic clinical test to assess color vision was 
performed with the pseudo-isochromatic Ishihara plates, 
which are most useful for detection of red–green congenital 
anomalies. Patients who successfully concluded the Ishihara 
test were then examined with more detailed methods.
A Farnsworth–Munsell 100 hue test (F-M 100 hue) was 
used and the results were processed with a sophisticated 
computer program which could score and plot the results of 
the test. The color vision testing was always performed for 
each eye separately using the best corrected refraction for 
short sight under speciﬁ  c lighting (daylight) conditions and 
at 45° to the plate surface.
The quantiﬁ  cation of the color vision defects was based 
on the TES and we calculated the change in total number of 
errors during follow-up.
Follow-up
Patients were followed up every six months and were tested 
for VA, IOP, optic nerve head appearance, color vision, 
and HVF test (SITA, standard). In case of any alteration in 
the HVF test, a repetition of the examination was necessary 
within a month in order to conﬁ  rm the new ﬁ  ndings.
Statistical processing
Paired t-test was used for the statistical analysis, which 
is a variable criterion based on repeated measurements 
comparing the mean difference in the scores of the standard 
F-M 100 hue between two different periods of time.
In some occasions a two-sample equal variance test 
(homoscedastic test) was applied; it is a variable criterion 
used to compare the mean of two samples that are unequal, 
heterogeneous and irrelevant.
The Pearson r coefﬁ  cient factor was calculated for the 
determination of the relevance between two variables, which 
is frequently used to establish the degree and the direction 
of correlation in arithmetical variables.
Results
Ninety-nine eyes of 56 patients were ﬁ  nally included in 
our study and underwent statistical analysis of their results 
from 136 eyes of 84 patients who participated initially in 
the survey.
The age of patients ranged from 19 to 64 years (mean age 
was 43.7). Nineteen patients were male and 37 female. The 
follow up time varied between 4 to 6 years with an average 
follow up of 4.7 years (± 0.6 SD).
Fifty-six eyes (56.6%) developed during the course 
of the study visual ﬁ  eld defects which were attributed to 
glaucomatous changes, while the other 43 eyes (43.4%) 
showed no functional or anatomical changes.
Table 1 shows in detail the mean value and the SD of the 
TES during color vision assessment in patients who developed 
glaucoma compared to those who remained without glauco-
matous changes from the beginning of the survey until 12, 
24, 36, and 48 months of follow-up, respectively. We observe 
that the difference of mean values between the two groups 
is statistically very signiﬁ  cant (p  0.001).
The mean value and the SD of the TES recorded in the 
initial test and the ﬁ  rst follow up 12 months later in patients 
that developed glaucoma in our study are summarized in 
Table 2. The Student’s t-test for paired samples had a value 
of t = –9.08 and a level of signiﬁ  cance p  0.001.
Table 3 provides the mean values and the SD of the TES 
in F-M 100 hue in the ﬁ  rst examination and the ﬁ  rst follow-up 
12 months later in patients who did not show glaucomatous 
changes during the study time. The Student’s t-test for paired 
samples had a value of t = –1.1 and p = 0.276 which is not 
statistically signiﬁ  cant.
The mean deviation (MD) and the CSPD of HVF-tests 
of all eyes were recorded in the 48th month of follow-up 
and were compared to the respective values in 0, 12, 24, 36, 
and 48 months. The Pearson’s coefﬁ  cient for both variables 
Table 1 Total error score (± SD) in follow-up period
Baseline 12 months 24 months 36 months 48 months
OH 75.51 (± 31.57) 77.62 (± 35.92) 85.46 (± 36.12) 89.51 (± 39.8) 93.62 (± 43.56)
POAG 157.89 (± 31.79) 178.51 (± 34.54) 195.03 (± 41.21) 211.51 (± 35.71) 232.26 (± 31.8)
t-value –12.816 –14.155 –13.823 –16.029 –18.304
Abbreviations: OH, ocular hypertension; POAG, primary open-angle glaucoma; SD, standard deviation.Clinical Ophthalmology 2009:3 254
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was high in all tests and extremely statistically signiﬁ  cant 
(p  0.001) (Table 4).
The graphical representation of the patients’ color vision 
illustrates the fact that the predominant color deﬁ  ciency 
(71%) is type III (blue–yellow), while 24% does not have a 
certain color axis (diffuse lesion) and only 5% of the defects 
take place on the red–green axis (Figure 1).
Discussion
The number of female patients included in the study was 
much higher than the male ones. This result can be attributed 
to the fact that the prevalence of congenital color vision 
defects is reported to be approximately 8% in males and 
only 0.4% in females because these anomalies have mainly 
an X-linked inheritance.17
The exclusion of patients suffering from cataract justiﬁ  es 
the relatively young age group of our study (average 
43.7 years). The effect of age in color perception is well 
justiﬁ  ed and is a factor that can cause difﬁ  culties to distinguish 
between age-related deterioration in chromatic discrimination 
ability and deterioration caused by glaucomatous changes.18 
Sample and colleagues studied color perception and concluded 
that there is a statistically signiﬁ  cant difference in color defects 
between patients suffering from POAG or OH compared with 
normal subjects of the same age.16 In our study we took into 
consideration the known inﬂ  uence of age and especially the 
existence of cataract in elderly patients and thus we excluded 
patients who presented with lens opaciﬁ  cation at any time 
during the study.
One of the limitations of our study is that we used the 
Ishihara pseudoisochromatic plates as a screening tool, in 
order to exclude patients with congenital color vision defects. 
The Ishihara plates, however, do not screen for yellow–blue 
defects, thus allowing the (small although existing) possibility 
of having recruited patients with congenital yellow–blue 
defects. However the tritanomalous patients or tritanopes 
represent only a small percentage (1%) of patients with 
congenital color vision defects. Another limitation would 
be that the central corneal thickness of the patients was not 
taken into account before classiﬁ  cation as OH.
Glaucoma effect
There is evidence that IOP does not have a Gaussian 
distribution and many deviations appear in a large number 
of individuals. In other words there is a tendency to record 
higher IOP, which increases with age.19,20
Our results showed that within ﬁ  ve years of follow-up, 
56.6% of the patients suffering from OH developed glaucoma. 
This is an extremely high percentage compared to other stud-
ies in the international bibliography.19–23
The high incidence of developing glaucoma in this study 
can be attributed to several reasons. The patients’ sample 
was taken from the glaucoma department and not randomly 
selected from the general population, which means that there 
were a high number of patients with glaucoma family history. 
Some patients had already POAG in the contralateral eye 
and thus it was very probable to develop the same disease 
in the investigated eye during follow up. As a result of the 
aforementioned remarks we strongly believe that the percent-
age of patients who developed glaucoma in our study is not 
representative for OH patients in the general population.
Color defect
The use of psychophysical and electrophysiological tests for 
checking the function of speciﬁ  c parts in the visual pathway 
seems to be a useful tool for the early detection of glauco-
matous changes. In addition, the conclusions of relevant 
studies can assist in understanding the mechanisms of visual 
deterioration in patients suffering early glaucoma.24,25
The defects in other psychophysical functions, including 
color vision deﬁ  cits, reduced contrast sensitivity, loss of pat-
tern discrimination, and reduction of movement discrimina-
tion which appeared prior to HVF defects, strengthened the 
suggestion that these general damages occur before the onset 
of glaucomatous changes in visual ﬁ  eld testing.24–32
Our results demonstrated that patients who developed 
POAG manifest signs of deteriorating color discrimination 
Table 2 Comparison of the initial test (TES0) and the ﬁ  rst follow up 
test (TES12) regarding the color vision defects in glaucoma patients
Statistical data of the ﬁ  rst two tests in glaucoma patients
No. of eyes Mean SD SE
TES0 56 157.89 ±31.79 4.249
TES12 56 178.51 ±34.54 4.616
Abbreviations: SD, standard deviation; SE, standard error of mean; TES, total error 
score.
Table 3 Comparison of the initial test (TES0) and the ﬁ  rst follow 
up test (TES12) regarding the color vision defects in glaucoma-free 
patients
Data of the ﬁ  rst two tests in patients who did not develop glaucoma
No. of eyes Mean SD SE
TES0 43 75.51 ±31.57 4.815
TES12 43 77.62 ±35.93 5.479
Abbreviations: SD, standard deviation; SE, standard error of mean; TES, total error 
score.Clinical Ophthalmology 2009:3 255
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ability before the appearance of glaucomatous lesions in HVF 
tests. Simultaneously, the TES of these patients was statistically 
signiﬁ  cant different compared to the TES of patients who did 
not develop glaucoma during the study (Table 1).
All the previous results conﬁ  rm the fact that color vision 
deﬁ  ciencies precede the glaucomatous defects and obviously 
are a strong predictive factor for the future development 
of glaucoma in OH patients. In other words, color defects 
predetermine a group of OH patients who have a very high 
probability of developing glaucoma in later years regardless 
of the HVF test parameters.
The study of color vision deﬁ  ciency shows a signiﬁ  cant 
deterioration in those patients who later developed severe 
glaucomatous defects in the HVF tests (Table 2). In the con-
trary, patients who never appeared to have such defects had a 
TES in color perception testing that did not show major ﬂ  uc-
tuations (Table 3). Thus, we can conclude that the functional 
deﬁ  cits in color perception in POAG can be traced and 
develop in time, underlining a progressive qualitative and/or 
quantitative damage of retinal ganglion cells, which can be 
quantitatively evaluated by testing color vision perception. 
Quantiﬁ  cation of such a defect provides the opportunity of a 
follow-up and comparison of the tests’ ﬁ  ndings in repeated 
examinations, leading to the evaluation of the changes before 
these alterations could be assessed with HVF tests.
Lakowski and Drance12 observed in their study an 
increasing chromatic aberration towards the blue–yellow 
axis (34%–74%) for respective deteriorating defects in the 
HVF tests in glaucoma patients.
In the present study, the investigation of the correlation 
between TES and MD, as well as between TES and CSPD 
was performed by determining the Pearson correlation 
coefﬁ  cient and suggested a statistically signiﬁ  cant correlation 
between the two variables (Table 4 and Figure 2).
Color deﬁ  ciency axis
The study of chromatic diagrams proved that blue–yellow 
(tritan-like) defects are the commonest type in POAG and 
OH patients, which is consistent with bibliography. François 
and Verriest33 mentioned a 60% blue–yellow defect in patients 
suffering from POAG in contrast to only 3% of red–green 
defects. Based on other reports which used the Farnsworth 100 
Hue test, in patients with POAG, typical prevalence for blue–
yellow defects was ranging between 34% and 85%.5,10–12,28,32
Several theories have been introduced in order to explain 
the predominance of tritan-like defects in POAG, including: a) 
short wavelength cones or their neuronal connections are less 
able to resist the effects of raised IOP, and b) there is selective 
damage to blue–yellow sensitive ganglion cells or their axons. 
Blue–yellow ganglion cells have larger receptive ﬁ  elds, are 
larger than red–green cells and have a unique morphology and 
connectivity to second order neurons, which make blue–yellow 
ganglion cells more susceptible to IOP-related damage.4
Table 4 A summary of the values of Pearson r correlation coefﬁ  cient, 
the TES from 0–48 months in relation to the MD, and the CPSD after 
48 months of follow-up
Correlation coefﬁ  cients between color perception and HVF-test 
results
TES0 TES12 TES24 TES36 TES48
MD48 −0.8515 −0.8855 −0.8944 −0.9114 −0.9217
CPSD48 0.6857 0.7000 0.7027 0.7192 0.7344
Abbreviations: CPSD, corrected pattern standard deviation; MD, mean deviation; 
TES, total error score.
71%
5%
Blue
Green–Red
Diffuse
24%
Figure 1 Graphical representation of the color vision axis defect.Clinical Ophthalmology 2009:3 256
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Yamazaki and colleagues34,35 have found greater color 
vision losses in high tension POAG compared with normal 
tension glaucoma, suggesting that there may be two separate 
mechanisms of damage to the visual function in glaucoma. 
One mechanism operates as a result of elevated IOP and 
is responsible for central and paracentral visual defects, 
including chromatic discrimination loss and the second 
mechanism is independent of the level of IOP.
Other researchers propose that the disturbance of 
blue–yellow vision should not be attributed to selective 
lesion, but to the relative scarcity of ganglion cells which 
code blue–yellow signals and the relatively little overlap 
between adjacent receptive ﬁ  elds of these ganglion cells. As a 
consequence, although only a few ganglion cells may cease to 
function, there is preferential impairment of the blue–yellow 
discrimination threshold compared with red–green, even if the 
proportion of damaged ﬁ  bers is the same for both types.8,29
Conclusions
From our study we can conclude the following:
1.  Color perception defects occur in a large number of OH 
patients suggesting a functional deterioration in vision 
even in case of an elevated IOP, which is just a few mmHg 
above the normal IOP value.
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Abbreviations: CPSD, corrected pattern standard deviation; MD, mean deviation;   TES, total error score.Clinical Ophthalmology 2009:3 257
Acquired color vision and visual ﬁ  eld defects
2.  Color vision deﬁ  ciency seems to precede glaucomatous 
defects in HVF tests, a fact that can play an important 
role as a predictive factor for developing glaucomatous 
changes in the future.
3.  The examination of chromatic perception with quantita-
tive methods in conjunction with the ease of recording and 
processing these data in a computer program can establish 
it as an important baseline examination method in OH.
4.  There is a statistically signiﬁ  cant correlation between the 
results of color perception testing and HVF indices.
5.  Glaucoma-related color vision defects affect mainly the 
blue–yellow stimuli.
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